These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 10778456

  • 1. [Effects of biphasic spiral CT, conventional and iron oxide enhanced MRI on therapy and therapy costs in patients with focal liver lesions].
    Helmberger T, Gregor M, Holzknecht N, Rau H, Scheidler J, Reiser M.
    Rofo; 2000 Mar; 172(3):251-9. PubMed ID: 10778456
    [Abstract] [Full Text] [Related]

  • 2. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC, Fauda V, Scaramuzza D, Vergnaghi D.
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [Abstract] [Full Text] [Related]

  • 3. [Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media].
    Bartolotta TV, Midiri M, Galia M, Carcione A, De Maria M, Lagalla R.
    Radiol Med; 2001 Apr; 101(4):219-29. PubMed ID: 11398050
    [Abstract] [Full Text] [Related]

  • 4. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F, Castrucci M, Sironi S, Livraghi T, Venturini M, Salvioni M, Del Maschio A.
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [Abstract] [Full Text] [Related]

  • 5. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K, Strobel D, Bernatik T, Blank W, Friedrich-Rust M, Herbay Av, Dietrich CF, Strunk H, Kratzer W, Schuler A.
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [Abstract] [Full Text] [Related]

  • 6. Preoperative assessment of liver metastasis originating from colorectal carcinoma: is super paramagnetic iron oxide particles-magnetic resonance imaging (SPIO-MRI) useful for screening?
    Nanashima A, Takeshita H, Sawai T, Sumida Y, Abo T, Tanaka K, Nonaka T, Sengyoku H, Hidaka S, Yasutake T, Nagayasu T.
    Hepatogastroenterology; 2008 Aug; 55(86-87):1750-3. PubMed ID: 19102384
    [Abstract] [Full Text] [Related]

  • 7. The clinical impact of magnetic resonance imaging in diagnosing focal hepatic lesions and suspected cancer.
    Shah AJ, Parsons B, Pope I, Callaway M, Finch-Jones MD, Thomas MG.
    Clin Imaging; 2009 Aug; 33(3):209-12. PubMed ID: 19411027
    [Abstract] [Full Text] [Related]

  • 8. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
    Liu X, Xu YK, Huang QL, Wu YK.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, Sano M, Kato S, Kitamura T, Fatima Z, Fukushima K, Iino H, Mori Y, Fujii H, Araki T.
    J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of hepatic metastases from colorectal carcinoma with MR-superparamagnetic iron oxide.
    Vidiri A, Carpanese L, Annibale MD, Caterino M, Cosimelli M, Zeuli M, David V, Crecco M.
    J Exp Clin Cancer Res; 2004 Mar; 23(1):53-60. PubMed ID: 15149151
    [Abstract] [Full Text] [Related]

  • 12. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
    Kubaska S, Sahani DV, Saini S, Hahn PF, Halpern E.
    Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
    [Abstract] [Full Text] [Related]

  • 13. [Detectability of focal liver lesions: comparison of MRI at 1.5 T and dynamic spiral CT].
    Urhahn R, Adam G, Keulers P, Kilbinger M, Günther RW.
    Rofo; 1996 Apr; 164(4):301-7. PubMed ID: 8645863
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Superparamagnectic iron oxide-enhanced magnetic resonance for tumor surveillance in cirrhotic liver before liver transplantation with explanted liver correlation.
    Tsang LL, Chen CL, Huang TL, Chen TY, Ou HY, Eng HL, Concejero A, Yu CY, Chen HL, Cheng YF.
    Transplant Proc; 2011 Jun; 43(5):1674-7. PubMed ID: 21693256
    [Abstract] [Full Text] [Related]

  • 18. [Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT].
    Jung G, Poll L, Cohnen M, Saleh A, Vogler H, Wettstein M, Willers R, Mödder U, Koch JA.
    Rofo; 2005 Nov; 177(11):1571-7. PubMed ID: 16302139
    [Abstract] [Full Text] [Related]

  • 19. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.
    Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M, Massironi S, Della Corte C, Ronchi G, Rumi MG, Biondetti P, Colombo M.
    Gut; 2010 May; 59(5):638-44. PubMed ID: 19951909
    [Abstract] [Full Text] [Related]

  • 20. [MRI with supermagnetic iron particles versus double-spiral CT in identification of malignant liver lesions].
    Müller RD, Vogel K, Neumann K, Hirche H, Barkhausen J, Stöblen F, Henrich H, Langer R.
    Rofo; 1998 May; 168(5):436-43. PubMed ID: 9617359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.